Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program

Nature Genetics

Volumn 50, Issue 11, 2018, Pages 1514-1523

  Klarin, Derek ^a,b,c   Damrauer, Scott M ^d,e   Cho, Kelly ^f   Sun, Yan V ^g   Teslovich, Tanya M ^h   Honerlaw, Jacqueline ^f   Gagnon, David R ^f,i   DuVall, Scott L ^d,j   Li, Jin ^k,l   Peloso, Gina M ⁱ   Chaffin, Mark ^b   Small, Aeron M ^d,m   Huang, Jie ^f   Tang, Hua ^k   Lynch, Julie A ^d,n   Ho, Yuk Lam ^f   Liu, Dajiang J ^o   Emdin, Connor A ^a,b   Li, Alexander H ^h   Huffman, Jennifer E ^f   Lee, Jennifer S ^k,l   Natarajan, Pradeep ^a,b   Chowdhury, Rajiv ^p   Saleheen, Danish ^d,e   Vujkovic, Marijana ^d,e   Baras, Aris ^h   Pyarajan, Saiju ^f,q   Di Angelantonio, Emanuele ^p   Neale, Benjamin M ^a,b   Naheed, Aliya ^r   Khera, Amit V ^a,b   Danesh, John ^p   Chang, Kyong Mi ^d,s   Abecasis, Gonçalo ^t   Willer, Cristen ^u   Dewey, Frederick E ^h   Carey, David J ^v   Concato, John ^m,w   Gaziano, J Michael ^f,q,x   O’Donnell, Christopher J ^f,x   Tsao, Philip S ^k,l   Kathiresan, Sekar ^a,b   Rader, Daniel J ^e,s,x   Wilson, Peter W F ^y,z   Assimes, Themistocles L ^k,l   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c Boston VA Healthcare System   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f VA BOSTON HEALTHCARE SYSTEM   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h AB)   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^o PENN STATE COLLEGE OF MEDICINE   (United States)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^s UNIVERSITY OF PENNSYLVANIA   (United States)

^t UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^u UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^v GEISINGER HEALTH SYSTEM   (United States)

^w VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^x HARVARD MEDICAL SCHOOL   (United States)

^y ATLANTA VA MEDICAL CENTER   (United States)

^z EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COLESTYRAMINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTOME; TRIACYLGLYCEROL;

ARTICLE; BIOBANK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DNA SEQUENCE; ELECTRONIC HEALTH RECORD; ETHNIC GROUP; EXOME; GENE FREQUENCY; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENETIC VARIATION; HISPANIC; HUMAN; ICD-9; LIPID BLOOD LEVEL; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; VETERAN; AGED; BLACK PERSON; BLOOD; CARDIOVASCULAR DISEASE; CAUCASIAN; ETHNOLOGY; FEMALE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; LIPID METABOLISM; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISPANIC AMERICANS; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VETERANS;

EID: 85054347138     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/s41588-018-0222-9     Document Type: Article

References (60)

1. Collins, R. What makes UK Biobank special? Lancet 379, 1173–1174 (2012)
2. Gaziano, J. M. et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214–223 (2016)
3. The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. J. Am. Med. Assoc. 302, 1993–2000 (2009)
4. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010)
5. Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013)
6. Chasman, D. I. et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 5, e1000730 (2009)
7. Albrechtsen, A. et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 56, 298–310 (2013)
8. Peloso, G. M. et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 94, 223–232 (2014)
9. Asselbergs, F. W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91, 823–838 (2012)
10. Below, J. E. et al. Meta-analysis of lipid-traits in Hispanics identifies novel loci, population-specific effects, and tissue-specific enrichment of eQTLs. Sci. Rep. 6, 19429 (2016)
11. Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017)
12. Lu, X. et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722–1730 (2017)
13. Sabatine, M. S. et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713–1722 (2017)
14. Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134–1144 (2016)
15. Dewey, F. E. et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123–1133 (2016)
16. Barter, P. J. et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109–2122 (2007)
17. Denny, J. C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102–1111 (2013)
18. The TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22–31 (2014)
19. Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr. & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264–1272 (2006)
20. Abul-Husn, N. S. et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science 354, aaf7000 (2016)
21. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015)
22. Tishkoff, S. A. et al. The genetic structure and history of Africans and African Americans. Science 324, 1035–1044 (2009)
23. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016)
24. Wright, F. A. et al. Heritability and genomics of gene expression in peripheral blood. Nat. Genet. 46, 430–437 (2014)
25. GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017)
26. Mancuso, N. et al. Integrating gene expression with summary association statistics to identify genes associated with 30 complex traits. Am. J. Hum. Genet. 100, 473–487 (2017)
27. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016)
28. Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017)
29. McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069–2070 (2010)
30. Khera, A. V. et al. Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease. J. Am. Med. Assoc. 317, 937–946 (2017)
31. Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016)
32. Sidore, C. et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47, 1272–1281 (2015)
33. Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014)
34. Diogo, D. et al. Phenome-wide association studies (PheWAS) across large “real-world data” population cohorts support drug target validation. Preprint at https://www.biorxiv.org/content/early/2017/11/13/218875 (2017)
35. Mahajan, A. et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559–571 (2018)
36. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015)
37. Klarin, D. et al. Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease. Nat. Genet. 49, 1392–1397 (2017)
38. Nelson, C. P. et al. Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat. Genet. 49, 1385–1391 (2017)
39. Gandotra, S. et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 364, 740–748 (2011)
40. Rani, J. et al. T2DiACoD: a gene atlas of type 2 diabetes mellitus associated complex disorders. Sci. Rep. 7, 6892 (2017)
41. Musunuru, K. et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363, 2220–2227 (2010)
42. Graham, M. J. et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N. Engl. J. Med. 377, 222–232 (2017)
43. Zhang, W. & Colman, R. W. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A. Blood 110, 1475–1482 (2007)
44. Maass, P. G. et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat. Genet. 47, 647–653 (2015)
45. Vandeput, F. et al. Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms. Proc. Natl Acad. Sci. USA 110, 19778–19783 (2013)
46. Bedenis, R. et al. Cilostazol for intermittent claudication. Cochrane Database Syst. Rev. 10, CD003748 (2014)
47. Tsuchikane, E. et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 100, 21–26 (1999)
48. Shinohara, Y. et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 9, 959–968 (2010)
49. Ahmad, F. et al. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci. Rep. 6, 28056 (2016)
50. Chung, Y. W. et al. Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury. Proc. Natl Acad. Sci. USA 112, E2253–E2262 (2015)
51. Harrison, S. C. et al. Genetic association of lipids and lipid drug targets with abdominal aortic aneurysm: a meta-analysis. JAMA Cardiol. 3, 26–33 (2018)
52. Lu, H. et al. Hypercholesterolemia induced by a PCSK9 gain-of-function mutation augments angiotensin II-induced abdominal aortic aneurysms in C57BL/6 mice—brief report. Arterioscler. Thromb. Vasc. Biol. 36, 1753–1757 (2016)
53. Voight, B. F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572–580 (2012)
54. Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345–1352 (2013)
55. Loh, P. R., Palamara, P. F. & Price, A. L. Fast and accurate long-range phasing in a UK Biobank cohort. Nat. Genet. 48, 811–816 (2016)
56. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012)
57. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006)
58. Winkler, T. W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014)
59. Hyde, C. L. et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet. 48, 1031–1036 (2016)
60. Zhou, X., Carbonetto, P. & Stephens, M. Polygenic modeling with Bayesian sparse linear mixed models. PLoS Genet. 9, e1003264 (2013)